bf/NASDAQ:ORGO_icon.jpeg

COM:ORGANOGENESIS

Organogenesis Holdings Inc.

  • Stock

Last Close

3.50

12/11 21:00

Market Cap

379.16M

Beta: -

Volume Today

501.45K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-208.70K
-
-2.09M
903.32%
-64.83M
2,996.16%
-40.45M
37.60%
17.95M
144.37%
94.90M
428.73%
15.53M
83.63%
4.95M
68.16%
depreciation and amortization
6.98M
-
9.43M
35.15%
7.47M
20.81%
16.68M
123.30%
18.03M
8.13%
23.45M
30.05%
deferred income tax
186K
-
111K
40.32%
112K
0.90%
-31.98M
28,650%
1.98M
106.19%
2.01M
1.62%
stock based compensation
303.80M
-
1.07M
-
936K
12.93%
1.66M
77.46%
3.86M
132.63%
6.55M
69.57%
9.00M
37.30%
change in working capital
-353.54K
-
1.51M
526.35%
-22.40M
1,586.16%
-9.67M
56.85%
-26.16M
170.65%
-39.29M
50.16%
-34.08M
13.25%
-18.07M
46.97%
accounts receivables
-7.11M
-
-4.69M
34.02%
-18.82M
301.30%
-30.23M
60.59%
-8.77M
70.99%
5.54M
163.16%
inventory
-5M
-
-11.06M
121.26%
-6.70M
39.44%
-9.30M
38.84%
-9.41M
1.16%
-8.18M
13.08%
accounts payables
-60K
-
4.70M
7,933.33%
-635K
113.51%
3.85M
705.83%
3.26M
15.26%
-108K
103.31%
other working capital
1.51M
-
-10.23M
778.76%
1.39M
113.56%
-4K
100.29%
-3.60M
89,925%
-19.16M
432.13%
-15.32M
20.02%
other non cash items
-303.80M
-
18.25M
-
6.12M
66.50%
5.78M
5.56%
17.80M
208.23%
16.85M
5.36%
9.59M
43.08%
net cash provided by operating activities
-562.23K
-
-586.60K
4.33%
-60.74M
10,254.34%
-33.53M
44.80%
6.80M
120.28%
61.98M
811.31%
24.86M
59.89%
30.92M
24.37%
investments in property plant and equipment
-1.86M
-
-6.23M
235.70%
-21.14M
239.19%
-31.22M
47.65%
-33.90M
8.58%
-24.36M
28.13%
acquisitions net
-5.82M
-
purchases of investments
sales maturities of investments
other investing activites
-310M
-
1K
-
2.13M
-
net cash used for investing activites
-310M
-
-1.86M
-
-6.23M
235.88%
-24.83M
298.35%
-31.22M
25.72%
-33.90M
8.58%
-24.36M
28.13%
debt repayment
-300K
-
-22.69M
-
-18.85M
16.92%
-25.91M
37.45%
-65.19M
151.58%
-3.01M
95.38%
-5.17M
71.69%
common stock issued
303.80M
-
92M
-
50.34M
45.28%
64.73M
28.58%
2.20M
96.60%
2.07M
5.82%
common stock repurchased
-6.76M
-
-737K
-
-648K
12.08%
dividends paid
-57.90M
-
-1.46M
-
-648K
55.65%
other financing activites
7.98M
-
-327.58K
104.11%
12.33M
3,864.60%
111.90M
807.37%
3.65M
96.74%
64.15M
1,657.59%
40K
99.94%
-332K
930.00%
net cash used provided by financing activities
311.48M
-
-327.58K
100.11%
81.64M
25,022.92%
78.73M
3.57%
42.47M
46.06%
-1.04M
102.44%
-2.20M
112.26%
-5.50M
150.34%
effect of forex changes on cash
net change in cash
914.01K
-
-914.18K
200.02%
19.05M
2,183.50%
38.97M
104.57%
24.44M
37.29%
29.72M
21.63%
-11.24M
137.81%
1.05M
109.33%
cash at beginning of period
126.06K
-
1.04M
725.04%
2.36M
126.72%
21.41M
807.76%
60.37M
182.04%
84.81M
40.48%
114.53M
35.05%
103.29M
9.81%
cash at end of period
1.04M
-
125.89K
87.90%
21.41M
16,903.48%
60.37M
182.04%
84.81M
40.48%
114.53M
35.05%
103.29M
9.81%
104.34M
1.01%
operating cash flow
-562.23K
-
-586.60K
4.33%
-60.74M
10,254.34%
-33.53M
44.80%
6.80M
120.28%
61.98M
811.31%
24.86M
59.89%
30.92M
24.37%
capital expenditure
-1.86M
-
-6.23M
235.70%
-21.14M
239.19%
-31.22M
47.65%
-33.90M
8.58%
-24.36M
28.13%
free cash flow
-562.23K
-
-586.60K
4.33%
-62.60M
10,570.91%
-39.76M
36.48%
-14.34M
63.93%
30.76M
314.43%
-9.04M
129.39%
6.55M
172.50%

All numbers in (except ratios and percentages)